Sort
261,768 grants matching “gene therapy”
Pathophysiology of Human Blood Cells
$861,806David A Williams · Boston Children'S Hospital · T32 · FY2024 · HL
Development of an Agonist of the TGF-beta Signaling Pathway to Treat Alzheimer's
$861,758Tony Wyss-Coray · Palo Alto Veterans Instit For Research · U01 · FY2012 · NS
Rectifying splicing mutations in blood disorders by gene editing
$861,736Daniel Evan Bauer · Boston Children'S Hospital · R01 · FY2022 · HL
Targeting Residual ASCVD Risk by Integrating Genetics and Clinical Data
$861,667Wei-Qi Wei · Vanderbilt University Medical Center · R01 · FY2025 · HL
Development of chimeric read amplification into a robust method for profiling targets of specific microRNAs and global amplification of all microRNA:mRNA pairings transcriptome-wide
$861,551Alexander A Shishkin · Eclipse Bioinnovations Inc · R44 · FY2022 · HG
Basic and Translational Research iPSC-based hematologic and vascular therapies
$861,527John P Cooke · Methodist Hospital Research Institute · U01 · FY2015 · HL
Laboratory of Genitourinary Cancer Pathogenesis Microscopy Core Facility
$861,527Ross Lake · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA
Innate Immune Clearance of Host-Adapted Pulmonary Pathogens
$861,458Alice S Prince · Columbia University Health Sciences · R35 · FY2021 · HL
Cholesterol reduction and cardiovascular risk in Type 1 diabetes
$861,449Ira Jay Goldberg · New York University School Of Medicine · R01 · FY2022 · HL
Disease prognostication and treatment response in rectal cancer patients
$861,424Karl Ried · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Study Susceptibility and Resistance to ApoE4 in Alzheimer's Disease
$861,422Yadong Huang · J. David Gladstone Institutes · R01 · FY2025 · AG
A physiologically relevant pre-clinical drug screening platform for Alzheimer's Disease and Traumatic Brain Injury with integrated stretchable microelectrodes
$861,339Oliver Graudejus · Bmseed, Llc · R44 · FY2024 · AG
Broadly Protective Bispecific Antibodies for Treatment of Ebola Virus Disease
$861,259M. Javad Aman · Integrated Biotherapeutics, Inc. · R42 · FY2017 · AI
Effects of Time-restricted Eating versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers among Adults with Obesity
$861,245Lisa Tussing-Humphreys · University Of Illinois At Chicago · R01 · FY2021 · CA
Innate Immune Clearance of Host-Adapted Pulmonary Pathogens
$861,202Alice S Prince · Columbia University Health Sciences · R35 · FY2020 · HL
Minimizing in vivo Drug Tolerance induction in tuberculosis.
$861,173David G Russell · Rutgers Biomedical And Health Sciences · U19 · FY2025 · AI
Synthetic Nanoparticle-antibody (SNAb) Based Depletion of Myeloid-Derived Suppressor Cells for TB Host-Directed Therapy
$861,166Jyothi Rengarajan · Emory University · R01 · FY2022 · AI
Biomarkers to Improve Targeting of Breast Cancer Prevention in Women with Atypical Hyperplasia
$861,161Amy C Degnim · Mayo Clinic Rochester · R01 · FY2022 · CA
Regulation of Aldosterone: The Effect of Statins
$861,153Gail Kurr Adler · Brigham And Women'S Hospital · R01 · FY2019 · HL
Targeting protein secretion in Mycobacterium tuberculosis
$861,105Tanya Parish · Seattle Children'S Hospital · R01 · FY2025 · AI
Mechanisms of Chromosome Maintenance in Bacteria
$861,097Dhruba K Chattoraj · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Aerosolized Epigenetic Therapy for Metastatic Lung Cancer
$861,087Matthew Reed · Nob Hill Therapeutics, Inc. · R44 · FY2023 · CA
Overcoming pre-existing immunity to AAV to enhance AAV-based HIV immunotherapies
$861,082Mauricio De Aguiar Martins · University Of Florida · R01 · FY2024 · AI
IGF::OT::IGF - GTRP AAV LAB SERVICES FOR DR. RADAR 1267; FY15; CAN 8470187; $860,987
$860,987Johannes Van Der Loo · Children'S Hosp Of Philadelphia · N01 · FY2015 · HL
Viral priming and targeting NK cells against solid tumor malignancies
$860,921Jeffrey S Miller · University Of Minnesota · R35 · FY2019 · CA